Article
Metabolic Signatures of Immune Checkpoint Inhibitor Response in Gynecologic Cancers: Insights from Flux Balance Analysis
2025-01-16
Abstract excerpt
<h4>ABSTRACT</h4> Modifiers of immune checkpoint inhibitor (ICI) responses in cancer patients are complex and remain poorly characterized, especially in gynecologic cancers. In this study, we explored fluxomic biomarkers that differentiate responders from non-responders to ICIs in a series of 49 patients with gynecologic cancers, including ovarian, cervical, and endometrial cancers. By applying metabolic enzyme e...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9cb207d6-186d-56f1-b3e2-836f75c029f0
- DOI
- 10.1101/2025.01.14.631240
